comprehensive -WSS

comprehensive

author：focus 2025-08-28 08:40:17 - browse：5

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Eli Lilly’s Zepbound improved liver scarring in mid

hotspot

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

FTC loses bid to block Novant's North Carolina hospital merger

FTC loses bid to block Novant's North Carolina hospital merger

Caitlin Bernard's story shows physicians can't shy from advocacy

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Structure Therapeutics oral GLP

knowledge

comprehensive

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why an extreme heat and wildfire smoke combination can be so dangerous

Jerome Adams on the need for new antivirals for Covid

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Trump demands the U.S. pay no more for drugs than other countries … again

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Affirmative action in medical school literally saved lives

Providers still hesitate to prescribe buprenorphine, study finds

Activists slam private health insurers over coverage restrictions

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

leisure time

Artificial intelligence advances fuel industry trying to preserve loved ones after death

In new study, freeze

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Russian special forces kill a gunman who broke into a private house near Moscow

Russian special forces kill a gunman who broke into a private house near Moscow

Providers still hesitate to prescribe buprenorphine, study finds

hotspot

entertainment

hotspot

hotspot